TD Cowen Maintains Buy on Roivant Sciences, Raises Price Target to $55

Benzinga · 1d ago
TD Cowen analyst Yaron Werber maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $50 to $55.